[an error occurred while processing this directive]
血管通路

经皮血管鞘血栓抽吸联合腔内血管成形术治疗急性自体动静脉内瘘血栓性闭塞

  • 刘海波 ,
  • 胡伟 ,
  • 张训 ,
  • 斯光晏SiGuangyan
展开
  • 1西南医科大学附属中医医院介入诊疗科

收稿日期: 2021-09-06

  修回日期: 2021-12-15

  网络出版日期: 2022-03-16

基金资助

西南医科大学附属中医医院自然科学青年项目(2020XYLH-069)

The efficacy of thrombus aspiration combined with percutaneous transluminal angioplasty via percutaneous vascular sheath in the treatment of acute thromboembolism in autologous arteriovenous fistula

  • LIU Hai-Bo ,
  • HU Wei ,
  • ZHANG Xun ,
  • SI Guang-YanSiGuangyan
Expand
  • 1Department of Interventional Radiology, The Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, Luzhou, Sichuan Province 646000, China

Received date: 2021-09-06

  Revised date: 2021-12-15

  Online published: 2022-03-16

摘要

【摘要】目的探讨经皮血管鞘血栓抽吸联合腔内血管成形术(percutaneous transluminal angioplasty, PTA)治疗急性自体动静脉内瘘(arteriovenous fistula,AVF)血栓性闭塞的临床疗效。方法选取西南医科大学附属中医院2014 年3 月~2020 年7 月因AVF 急性血栓性闭塞就诊的患者作为研究对象,回顾性收集患者的临床资料,根据治疗方式分组,即血栓抽吸组(血栓抽吸联合PTA)和局部溶栓组(局部溶栓联合PTA),比较2 种术式的手术成功率、手术后并发症发生率以及治疗后的1年初级通畅率,通过Kaplan-Meier分析评价通畅率。结果共纳入61例患者,其中血栓抽吸组28例,局部溶栓组33例,血栓抽吸组患者的手术解剖成功率和临床成功率分别为100%、96.4%,高于局部溶栓组96.9%、90.9%,2 组差异无统计学意义(χ2=0.863,P=0.353;χ2=0.753,P=0.385),血栓抽吸组术后并发症发生率(7.4%)稍高于局部溶栓组(6.7%),2 组差异无统计学意义(χ2=0.029,P=0.865);血栓抽吸组患者手术后第3、6、12 个月初级通畅率分别为96.3%、92.6%、74.1%,局部溶栓组分别为96.7%、76.7%、46.7%,2 组一年初级通畅率差异有统计学意义(χ2=4.158,P=0.041)。结论经皮血管鞘血栓抽吸联合PTA 是治疗急性自体动静脉内瘘血栓性闭塞的安全、有效的方法,可延长内瘘的使用寿命,尤其适用于有溶栓禁忌的患者。

本文引用格式

刘海波 , 胡伟 , 张训 , 斯光晏SiGuangyan . 经皮血管鞘血栓抽吸联合腔内血管成形术治疗急性自体动静脉内瘘血栓性闭塞[J]. 中国血液净化, 2022 , 21(03) : 209 -213 . DOI: 10.3969/j.issn.1671-4091.2022.03.016

Abstract

【Abstract】Objective To investigate the efficacy of thrombus aspiration combined with percutaneous transluminal angioplasty (PTA) via percutaneous vascular sheath in the treatment of acute thromboembolism in autologous arteriovenous fistula (AVF). Methods Patients with acute thrombotic occlusion of AVF treated in the Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University from March 2014 to July 2020 were selected as the research subjects. Their clinical data were recruited retrospectively. They were divided into thrombus aspiration group (thrombus aspiration combined with PTA) and local thrombolysis group (local thrombolysis combined with PTA). Surgical success rate, incidence of postoperative complications and primary patency rate after the treatment for one year were compared between the two groups. The patency rate was evaluated by Kaplan-Meier analysis. Results A total of 61 patients were enrolled in this study, including 28 cases in the thrombus aspiration group and 33 cases in the local thrombolysis group. The anatomical success rate and clinical success rate in the thrombus aspiration group were 100% and 96.4% respectively, higher than those of 96.9% and 90.9% respectively in the local thrombolysis group but without statistical significances (χ2=0.863 and 0.753, P=0.353 and 0.385). The incidence of postoperative complications
in the thrombus aspiration group (7.4%) was slightly higher than that in the local thrombolysis group (6.7%) but without statistical significance (χ2=0.029, P=0.865). The primary patency rates after the operation for 3, 6 and 12 months in the thrombus aspiration group were 96.3%, 92.6% and 74.1%, respectively, while those in the local thrombolysis group were 96.7%, 76.7% and 46.7%, respectively; the rates in the two groups were statistically significant (χ2=4.158, P=0.041). Conclusions Thrombus aspiration combined with PTA via percutaneous vascular sheath is a safe and effective method to treat acute thrombotic occlusion of AVF, especially for patients with contraindications of thrombolysis. This method can also prolong the survival time of AVF.

参考文献

[1]刘文虎, 孙雪峰, 林洪丽等.中国血液透析充分性临床实践指南[J].中华医学杂志, 2015, 95(34):2748-2753 [2]Vascular Access 2006 Work Group.Clinical practice guidelines for vascular access[J].Am J Kidney Dis, 2006, :- [3]NKF-DOQI Clinical Practice Guidelines for Vascular Access.National Kidney Foundation dialysis outcomes quality initiative. Am J Kidney Dis 1997; 30(4 Suppl. 3): S150–S191. [4]Silva MB Jr, Hobson RW, Pappas PJ, et al.A strategy for increasing use of autogenous hemodialysis access procedures:impact of preoperative noninvasive evaluation. J Vasc Surg.1998; 27(2):302–7. [5]Kazemzadeh GH, Modaghegh MHS, Ravari H, et al.Primary patency rate of native AVfistula:Long term follow up[J].Int J Clin Exp Med, 2012, 5(2):173-178 [6]Kim SM, Yoon KW, Woo SY, et al.Treatment strategies for cephalic arch stenosis in patients with brachiocephalic srteriovenous fistula[J]. Ann Vasc Surg, 2019, 54: 248-253 [7]Duque JC,Tabbara M,Martinez L,et al.Dialysis arteriovenous fistula failure and angioplasty: intimal hyperplasia and other causes of access failure[J].Am J Kidney Dis, 2016, 69(1):147-151 [8]Navuluri R, Regalado S.The KDOQI 2006 vascular access update and Fistula First program synopsis. Semin Intervent Radiol 2009; 26:122-4. [9]Al-Jaishi AA, Oliver MJ, Thomas SM, et al.Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 2014; 63:464-78. [10],Hingorani A, Ascher E, Kallakuri S, et al.Impact of reintervention for failing upper-extremity arteriovenous autogenous access for hemodialysis. J Vasc Surg 2001; 34:1004 –1009. [11],Berman S, Gentile A.Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance. J Vasc Surg 2001; 34:866 – 871. [12],Tordoir JH, Bode AS, Peppelenbosch N, Surgical or endovascular repair of thrombosed dialysis vascular access: is there any evidence? J Vasc Surg.2009 Oct; 50(4):953-6. [13],Mammen EF.Pathogenesis of venous thrombosis. Chest 1992; 102:640S-4S. [14],Gibson KD, Gillen DL, Caps MT, et al.Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J V asc Surg 2001; 34:694-700. [15], Y oung EW, Dykstra DM, Goodkin DA, et al.Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002; 61:2266-71. [16],Weigert AL, Schafer AI.Uremic bleeding: pathogenesis and therapy. Am J Med Sci 1998; 316:94-104. [17],Quencer KB, Oklu R.Hemodialysis access thrombosis. Cardiovasc Diagn Ther. 2017 Dec; 7(Suppl 3):S299-S308. [18],Knoll GA, Wells PS, Young D, et al.Clinch JJ, Rodger MA. Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol. 2005 Apr; 16(4):1108-14. [19],Chou CY, Kuo HL, Yung YF, et al.C-reactive protein predicts vascular access thrombosis in hemodialysis patients. Blood Purif 2006; 24:342-6. [20],Eleftheriadis T, Antoniadi G, Akritidou A, et al.A case report of recurrent vascular access thrombosis in a hemodialysis patient reveals combined acquired and inherited thrombophilia. Ther Apher Dial 2008; 12:190-2. [21]张树超, 祝成, 叶有新等.经皮腔内血管成形术结合药物溶栓治疗动静脉内瘘急性血栓形成的疗效观察[J].浙江大学学报医学版, 2019, 48(05):533-539 [22],Poulain F, Raynaud A, Bourquelot P, et al.Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas. Cardiovasc Intervent Radiol. 1991 Mar-Apr; 14(2):98-101. [23],Turmel-Rodrigues L, Sapoval M, Pengloan J, et al.Manual thromboaspiration and dilation of thrombosed dialysis access: mid-term results of a simple concept. J Vasc Interv Radiol. 1997 Sep-Oct; 8(5):813-24. [24],Turmel-Rodrigues L, Pengloan J, Rodrigue H, et al.Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int. 2000 Mar; 57(3):1124-40. [25]Goo DE, Kim YJ, Park ST, et al.Thromboaspiration of arteriovenous hemodialysis graft thrombosis using Desilets-Hoffman sheath: single-center experience. J Vasc Access. 2014 Sep-Oct; 15(5):401-8.
文章导航

/

[an error occurred while processing this directive]